Pfizer Inc.
Tetrahydroquinazoline derivatives useful as anticancer agents
Last updated:
Abstract:
Compounds of the general formula: ##STR00001## processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
Status:
Grant
Type:
Utility
Filling date:
1 Feb 2019
Issue date:
17 Mar 2020